This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
$0.43
Share price
4.59%
Change (1 day)
-74.69%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): NZ$1.17 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is NZ$1.13 Million. In 2023 the company made a revenue of NZ$0.02 Million a decrease over the revenue in the year 2022 that were of NZ$0.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | NZ$1.17 M | 4590.97% |
| 2023 | NZ$0.02 M | -94.46% |
| 2022 | NZ$0.45 M | |
| 2021 | N/A | -100% |
| 2020 | NZ$0.05 M | -98.81% |
| 2019 | NZ$4.6 M | -3.35% |
| 2018 | NZ$4.76 M | -32.74% |
| 2017 | NZ$7.09 M | -20.8% |
| 2016 | NZ$8.95 M | 2.56% |
| 2015 | NZ$8.73 M | -71.78% |
| 2014 | NZ$30.94 M | 1104.64% |
| 2013 | NZ$2.56 M | 29.74% |
| 2012 | NZ$1.97 M | -66.11% |
| 2011 | NZ$5.84 M | 35.15% |
| 2010 | NZ$4.32 M | -13.48% |
| 2009 | NZ$4.99 M | 169.83% |
| 2008 | NZ$1.85 M | 55.88% |
| 2007 | NZ$1.18 M | 42.82% |
| 2006 | NZ$0.83 M | 114.87% |
| 2005 | NZ$0.38 M | |
| 2004 | N/A | -100% |
| 2003 | NZ$1.17 M | -24.09% |
| 2002 | NZ$1.55 M | 195.12% |
| 2001 | NZ$0.52 M |